• Transactions
  • News
  • Events
  • Contact
  • SVB.com
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

SVB Leerink

Helping our clients move healthcare forward

  • Firm
    • About
    • Careers
    • News
  • Expertise
    • Investment Banking
    • Equity Research
    • Institutional Equities
    • Corporate Access
    • MEDACorp
  • Sectors
    • Biopharma
    • Medical Devices
    • Tools & Diagnostics
    • Healthcare Services
  • Log in
  • Transactions
  • News
  • Events
  • Contact
  • SVB.com

Research Archive

December 2020

Biopharma / Vax Series #4: Shibboleths – Short-Lived Immunity, Vaccine Scarcity, Local Mfg.

View research note
November 2020

Biopharma / COVID – The Beginning of the End as the Pieces Fall into Place

View research note
October 2020

Life Science Tools and Diagnostics / Diving Deeper Into Multi-Cancer Liquid Biopsy Screening Tests

View research note
September 2020

Biopharma / CD20xCD3 SmackDown: Let’s Get Ready to Rumble!!!

View research note
August 2020

It Ain’t Over Yet –COVID Vax Timeline Uncertain, Traditional Approach Preferred

View research note
July 2020

COVID Vaccine Series #1: Competitive Landscape, Timeline, and What to Expect

View research note
June 2020

GILD / Upgrading to OP ($94 PT) on Remdesivir Sales, Arcus and Other Pipeline Options / Outperform

View research note
May 2020

Biopharma/ Immuno-oncology: TIGIT & PVRIG Preview Heading into Catalyst-Rich Month

View research note
April 2020

Healthcare: Is COVID Serology Antibody Testing Really Ready For The Big Reopening?

View research note
March 2020

MEDACorp Alzheimer’s Panel Takeaways

View research note
January 2020

MERSANA THERAPEUTICS, INC. Time 2B Great: Previewing 1H20 NaPi2b

View research note
December 2019

2020 Outlook for Investing in Healthcare

View research note
November 2019

Biopharma / Highlights from SVB Leerink’s POLARxPRESS Bus Tour

View research note
October 2019

Life Science Tools and Diagnostics / Liquid Biopsy Insights Series: Assessing Test Performance and Technologies

View research note
September 2019

REGN / Is REGN Becoming the TIVO of Biopharma? / Outperform

View research note
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Partner With Us

We deliver a complete suite of capital market and advisory solutions to help our clients define and achieve their strategic, capital market, and investment objectives.

Contact Us

Footer

Firm

  • About
  • Careers
  • Events
  • Privacy Notice
  • Important Disclosures

Expertise

  • Capital Markets
  • M&A Advisory
  • Institutional Equities
  • Equity Research
  • MEDACorp
  • Terms of Use

Sectors

  • Biopharma
  • Medical Devices
  • Tools & Diagnostics
  • Healthcare Services
  • Member FINRA/SIPC, www.finra.org

Other

  • News
  • Transactions
  • Contact
  • SVB.com
AN SVB COMPANY